<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1028-4818</journal-id>
<journal-title><![CDATA[Multimed]]></journal-title>
<abbrev-journal-title><![CDATA[Multimed]]></abbrev-journal-title>
<issn>1028-4818</issn>
<publisher>
<publisher-name><![CDATA[Centro Provincial de Información de Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1028-48182021000600011</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Factores de riesgo y lesiones macrovasculares en pacientes con diabetes mellitus tipo 2]]></article-title>
<article-title xml:lang="en"><![CDATA[Risk factors and macrovascular lesions in patients with type 2 diabetes mellitus]]></article-title>
<article-title xml:lang="pt"><![CDATA[Fatores de risco e lesões macrovasculares em pacientes com diabetes mellitus tipo 2]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lago Santiesteban]]></surname>
<given-names><![CDATA[Yasel Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Labrada Tapia]]></surname>
<given-names><![CDATA[Domingo Ángel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Breijo Puente]]></surname>
<given-names><![CDATA[Alina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lago Santiesteban]]></surname>
<given-names><![CDATA[Diana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sosa García]]></surname>
<given-names><![CDATA[Daniel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Granma Centro de Atención al Diabético ]]></institution>
<addr-line><![CDATA[Bayamo Granma]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<volume>25</volume>
<numero>6</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1028-48182021000600011&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1028-48182021000600011&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1028-48182021000600011&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  entre las condiciones clínicas que causan riesgo cardiovascular la diabetes mellitus tipo 2 sobresale, y son las complicaciones macrovasculares en estos pacientes la principal causa de morbilidad y mortalidad.  Objetivo:  identificar la posible asociación entre factores de riesgo y el desarrollo de las lesiones macrovasculares en pacientes con diabetes tipo 2.  Métodos:  se realizó un estudio analítico de tipo casos y controles (relación 1:2), en pacientes con DM tipo 2 ingresados en el Centro de Atención al Diabético (CAD) de Bayamo, provincia Granma, en el periodo comprendido entre 2017 y 2019.  Resultados:  el análisis de las variables cualitativas el no control de la diabetes fue el factor más importante (OR = 13,05; IC = 5,750-29,633; p = 0,000) seguido de electrocardiograma patológico (OR = 10,61; IC = 4,269-26,396; p = 0,000). El análisis univariado de las variables cuantitativas, la edad mayor de 55 años y la hipertensión arterial independientemente del tipo (sistólica o diastólica) fueron los factores más frecuentes. El análisis multivariado a través de una regresión logística binaria, el factor de mayor importancia fue el no control de la diabetes mellitus (IC = 6,758-27,639; p = 0,00) seguido del síndrome metabólico (OR = 15,837; IC = 2,869-17,424; p = 0,00) la hipertensión no controlada (OR = 11,319; IC = 2,016-63,542; p = 0,000).  Conclusiones:  los factores de riesgo de mayor relevancia para el desarrollo de la enfermedad cardiovascular en los pacientes con diabetes tipo 2 fueron diabetes mellitus descontrolada, el síndrome metabólico y la hipertensión arterial no controlada.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction: among Théo clinical conditions that cause cardiovascular risk, type 2 diabetes mellitus stands out, and macrovascular complications in these patients are the main cause of morbidity and mortality.  Objective: to identify the possible association betei risk factors and the development of macrovascular lesions in patients with type 2 diabetes.  Methods: an analytical case-control study (1: 2 ratio) was carried out in patients with type 2 DM admitted to the Diabetic Care Center (CAD) of Bayamo, Granma province, in the period between 2017 and 2019 .  Results: the analysis of the qualitativos variables, the non-control of diabetes was the most important factor (OR = 13.05; CI = 5.750-29.633; p = 0.000) followed by pathological electrocardiogram (OR = 10.61; CI = 4.269 -26.396; p = 0.000). Univariate analysis of quantitative variables, age over 55 years and arterial hypertension regardless of type (systolic or diastolic) were the most frequent factors. The multivariate analysis through a binary logistic regressos, the most important factor was the non-control of diabetes mellitus (CI = 6.758-27.639; p = 0.00) followed by the metabolic syndrome (OR = 15.837; CI = 2.869- 17,424; p = 0.00) uncontrolled hypertension (OR = 11.319; CI = 2.016-63.542; p = 0.000).  Conclusions: the most relevant risk factors for the development of cardiovascular disease in patients with type 2 diabetes were uncontrolled diabetes mellitus, metabolic syndrome and uncontrolled arterial hypertension.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução:  dentre as condições clínicas que causam risco cardiovascular, destaca-se o diabetes mellitus tipo 2, sendo as complicações macrovasculares nesses pacientes a principal causa de morbimortalidade.  Objetivo:  identificar a possível associação entre fatores de risco e o desenvolvimento de lesões macrovasculares em pacientes com diabetes tipo 2.  Métodos:  foi realizado um estudo analítico caso-controle (proporção 1: 2) em pacientes com DM tipo 2 internados no Centro de Atenção ao Diabético (CAD) de Bayamo, província de Granma, no período de 2017 a 2019.  Resultados:  na análise das variáveis &#8203;&#8203;qualitativas, o não controle do diabetes foi o fator mais importante (OR = 13,05; IC = 5,750-29,633; p = 0,000) seguido do eletrocardiograma patológico (OR = 10,61; IC = 4,269 -26,396; p = 0,000). A análise univariada das variáveis &#8203;&#8203;quantitativas, idade acima de 55 anos e hipertensão arterial independente do tipo (sistólica ou diastólica) foram os fatores mais frequentes. Na análise multivariada por meio de regressão logística binária, o fator mais importante foi o não controle do diabetes mellitus (IC = 6,758-27,639; p = 0,00) seguido da síndrome metabólica (OR = 15,837; IC = 2,869- 17.424; p = 0,00) hipertensão não controlada (OR = 11,319; IC = 2,016-63,542; p = 0,000).  Conclusões: os fatores de risco mais relevantes para o desenvolvimento de doenças cardiovasculares em pacientes com diabetes tipo 2 foram diabetes mellitus não controlada, síndrome metabólica e hipertensão arterial não controlada.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Diabetes mellitus]]></kwd>
<kwd lng="es"><![CDATA[Macroangipatia]]></kwd>
<kwd lng="es"><![CDATA[Enfermedad cardiovascular]]></kwd>
<kwd lng="es"><![CDATA[Síndrome metabólico]]></kwd>
<kwd lng="en"><![CDATA[Diabetes mellitus]]></kwd>
<kwd lng="en"><![CDATA[Macroangipatia]]></kwd>
<kwd lng="en"><![CDATA[Cardiovascular disease]]></kwd>
<kwd lng="en"><![CDATA[Metabolic syndrome]]></kwd>
<kwd lng="pt"><![CDATA[Diabetes mellitus]]></kwd>
<kwd lng="pt"><![CDATA[Macroangipatia]]></kwd>
<kwd lng="pt"><![CDATA[Doença cardiovascular]]></kwd>
<kwd lng="pt"><![CDATA[Síndrome metabólico]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<collab>American Diabetes Association</collab>
<article-title xml:lang=""><![CDATA[Diagnosis and classification of diabetes mellitus]]></article-title>
<source><![CDATA[Diabetes care]]></source>
<year>2005</year>
<volume>28</volume>
<numero>37</numero>
<issue>37</issue>
<page-range>5-10</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<collab>American Diabetes Association</collab>
<article-title xml:lang=""><![CDATA[Classification and diagnosis of diabetes: standards of medical care in diabetes 2019]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2019</year>
<volume>42</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>13-28</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piepoli]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Hoes]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
<name>
<surname><![CDATA[Agewall]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Albus]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Brotons]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Catapano]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR)]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2016</year>
<volume>37</volume>
<numero>29</numero>
<issue>29</issue>
<page-range>2315-81</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ritsinger]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Hero]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Svensson]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Saleh]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Lagerqvist]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Eeg-Olofsson]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Characteristics and Prognosis in Women and Men With Type 1 Diabetes Undergoing Coronary Angiography: A Nationwide Registry Report]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2018</year>
<volume>41</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>876-83</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Furst]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Retrospective study finds that cancer drug also lowers blood glucose]]></article-title>
<source><![CDATA[Mayo Clinic]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>MINSALUD</collab>
<source><![CDATA[Análisis de la situación de salud en Colombia (ASIS)]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
<publisher-name><![CDATA[Dirección de Epidemiología y Demografía]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<collab>Misterio de Salud Pública</collab>
<source><![CDATA[Anuario Estadístico de Salud de Cuba 2019.]]></source>
<year>2020</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[MINSAP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gnatiuc]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Herrington]]></surname>
<given-names><![CDATA[WG]]></given-names>
</name>
<name>
<surname><![CDATA[Halsey]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tuomilehto]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Fang]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies]]></article-title>
<source><![CDATA[The lancet Diabetes &amp; Endocrinology]]></source>
<year>2018</year>
<volume>6</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>538-46</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Consentino]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Grant]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Aboyans]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Bailey]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ceriello]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes (EASD)]]></article-title>
<source><![CDATA[Revista Española de Cardiología]]></source>
<year>2020</year>
<volume>73</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>404.e1-404.e59</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lara-O'Farrill]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[O'Farrill Fernández]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez de Santelices Cuervo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interacción Genoambiente en la génesis de la DM2]]></article-title>
<source><![CDATA[Acta Médica del Centro]]></source>
<year>2017</year>
<volume>11</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Care]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes 2018]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2018</year>
<volume>41</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>105-18</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<collab>Emerging Risk Factors Collaboration</collab>
<article-title xml:lang=""><![CDATA[Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>2010</year>
<volume>375</volume>
<page-range>2215-22</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Salinero-Fort]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Burgos-Lunar]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lahoz]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mostaza]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Abánades Herranz]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Laguna-Cuesta]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community Based The SPREDIA-2 Study]]></article-title>
<source><![CDATA[PLoS ONE]]></source>
<year>2016</year>
<volume>11</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez Aliaga]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[González Aguilera]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Maceo Gómez]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factors associated to hypertensive heart disease development: a prospective cohort study in Bayamo, Cuba]]></article-title>
<source><![CDATA[Medwave]]></source>
<year>2016</year>
<volume>16</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valdés Ramos]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Espinosa Benítez]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo asociados con la aparición de enfermedad arterial periférica en personas con diabetes mellitus tipo 2]]></article-title>
<source><![CDATA[Rev Cubana de Med]]></source>
<year>2013</year>
<volume>52</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>4-13</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
